NASDAQ: CYTKCytokinetics Revenue
Cytokinetics revenue was $87.21M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $1.9M, down 97.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CYTK annual revenue was $18.5M, with 145.3% growth year-over-year.
CYTK past revenue growth
How has CYTK's revenue growth performed historically?
Company
2,609.26%
Industry
284.61%
Market
22.91%
CYTK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CYTK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CYTK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
CYTK revenue history
Current Revenue
$87.2M
Current Earnings
-$751.9M
Current Profit Margin
-862.2%
Be the first to know when CYTK announces revenue.
CYTK Revenue History By Year
| CYTK Yearly Revenue | CYTK Revenue | CYTK Change | CYTK Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $18.47M | $10.94M | +145.34% |
| 2023-12-31 | $7.53M | -$87.06M | -92.04% |
| 2022-12-31 | $94.59M | $24.16M | +34.30% |
| 2021-12-31 | $70.43M | $14.60M | +26.15% |
| 2020-12-31 | $55.83M | $28.96M | +107.79% |
| 2019-12-31 | $26.87M | -$4.63M | -14.71% |
| 2018-12-31 | $31.50M | $18.13M | +135.64% |
| 2017-12-31 | $13.37M | -$93.04M | -87.44% |
| 2016-12-31 | $106.41M | $77.75M | +271.30% |
| 2015-12-31 | $28.66M | -$18.28M | -38.95% |
| 2014-12-31 | $46.94M | $16.29M | +53.16% |
| 2013-12-31 | $30.65M | $23.09M | +305.45% |
| 2012-12-31 | $7.56M | $3.56M | +88.98% |
| 2011-12-31 | $4.00M | $1.42M | +55.22% |
| 2010-12-31 | $2.58M | -$78.96M | -96.84% |
| 2009-12-31 | $81.54M | $69.12M | +556.51% |
| 2008-12-31 | $12.42M | -$1.20M | -8.82% |
| 2007-12-31 | $13.62M | $10.50M | +335.63% |
| 2006-12-31 | $3.13M | -$5.79M | -64.91% |
| 2005-12-31 | $8.91M | -$4.53M | -33.70% |
| 2004-12-31 | $13.44M | $2.87M | +27.09% |
| 2003-12-31 | $10.58M | -$819.00k | -7.19% |
| 2002-12-31 | $11.40M | $2.93M | +34.61% |
| 2001-12-31 | $8.47M | N/A | N/A |
Cytokinetics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.